Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 3

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 3
---
 Exchange Warrants to purchase an aggregate of 500,000 shares of Common Stock at an exercise price of $40.00 per share(subject to adjustment as described in this prospectus). The October 2024 Noteholder Warrants were issued pursuant to our Registration Statement on Form S-3 (File No. 333-276245) (the “Original Registration Statement”), which registration statement was subsequently converted to a registration statement on Form S-1 to continue the registration of the shares of Common Stock issuable by the Company upon exercise of the October 2024 Noteholder Warrants (File No. 333-280882) (the Original Registration Statement, as so continued, the “Continuation Registration Statement”) due to the Company’s ineligibility to use a registration statement on Form S-3. For more information regarding the Exchange Warrants, see the section titled “Description of the Exchange Warrants”.

The September 2025 Warrants were issued on September 30, 2025, pursuant to a Warrant Exercise Agreement (the “Warrant Exercise Agreement”) (a copy of which is filed as an exhibit to the registration statement of which this prospectus forms a part) that we entered into on such date with certain holders of then existing December 2024 RDO Common Warrants (as defined below) to purchase an aggregate of 179,236 shares of Common Stock that were previously issued on December 13, 2024 (such holders, the “December 2024 RDO Warrant Holders”). Pursuant to the Warrant Exercise Agreement, the December 2024 RDO Warrant Holders exercised in full their respective December 2024 RDO Common Warrants in exchange for, among other things, the Company’s agreement to issue the September 2025 Warrants with an exercise price of $20.00 per share. For more information regarding the September 2025 Warrants, see the section titled “Description of the September 2025 Warrants”.

The November 2025 Investor Warrant was issued on November 25, 2025, pursuant to a Warrant Inducement Agreement (the “Warrant Inducement Agreement”) (a copy of which is filed as an exhibit to the registration statement of which this prospectus forms a part) that we entered into on November 23, 2025 with a certain institutional investor (the “Exercising Investor”). Pursuant to the Warrant Inducement Agreement, the Exercising Investor exercised (the “Exercise”) warrants